Valuation adjustments and down rounds are expected to proliferate in Australia’s technology sector in the next 12 months. Investors are busy scrutinising business models for signs of vulnerability
China-based Enpower Greentech, which claims to be a pioneer in next-generation all-solid-state batteries (ASSBs), has raised more than USD 20m in an extended Series A round led by Sequoia Capital China and Dayone Capital.
GetVantage, a provider of revenue-based financing to Indian start-ups, has secured USD 36m in funding led by Varanium Nexgen Fintech Fund, DMI Sparkle Fund, Chiratae Ventures, and Dream Incubator Japan.
Imposing punitive terms on founders in response to governance concerns can prove counterproductive to long-term growth as start-ups move through funding rounds and stipulations intensify, a Singapore Venture Capital & Private Equity Association (SVCA)...
PE investment in China biotech has collapsed amid failed IPO processes and disputed valuations. Pockets of activity remain, though questions around commercialisation have yet to be answered
SeaTown Holdings International, an alternatives manager owned by Temasek Holdings, has provided a USD 50m Series B round for Vietnamese e-commerce enabler OnPoint.
Therorna, a China-based biotech company specializing in vaccines and drugs based on circular RNA technology, has raised USD 42m in Series A funding.
Temasek Holdings has led a USD 80m Series B round for Shanghai-based bio-manufacturing start-up Mojia Biotech.
Beijing-based HeliXon, an artificial intelligence-enabled developer of protein-based drugs, has raised CNY 500m (USD 75m) in Series A funding led by 5Y Capital. Other investors include Gaorong Capital and Neumann Capital.
Openspace Ventures and VI Group have led a USD 25m Series B round for Vietnamese digital investment platform Finhay.
East Ventures has led a USD 29m Series B round for Malaysia-based direct-to-consumer (DTC) social e-commerce company RPG Commerce.
Singapore’s Rainforest, an aggregator of Amazon marketplace sellers, has raised a USD 45m round led by Southern Capital, which provided USD 15m.
Zhongchu Guoneng Technology is leading China’s push into compressed air energy storage as a means of harnessing fast-rising yet unstable wind and solar capacity. Tsinghua Holdings Capital is among the backers
SOSV sees parallels between the e-commerce awakenings in Pakistan and China, though 20 years apart. Dastgyr has positioned itself at the fore, but it wants to be asset-light rather than asset-heavy
Indonesia’s Ekta, a blockchain ecosystem operator with a non-fungible token (NFT) marketplace and eponymous cryptocurrency, has raised USD 60m from US-based Global Emerging Markets (GEM).
Vulcan Capital, an investment vehicle established by Microsoft co-founder Paul Allen, has led a USD 10.5m Series A round for Singapore-based microbe analytics start-up Amili.
Dastgyr, a Pakistan-based B2B e-commerce marketplace, has raised USD 37m in Series A funding led by Veon, an Amsterdam-listed telecom provider that owns Pakistan’s largest mobile network.
Indonesian consumer payments platform Flip has upsized its Series B round to more than USD 100m with the addition of Tencent Holdings and Block – formerly Square – to the investor roster and re-up from Insight Partners.
Traditional VCs are becoming more active in Asia’s blockchain and web3 space, despite structural and philosophical obstacles to participation. Can they withstand the crypto winter?
Singapore’s Tessa Therapeutics has developed a cancer drug that appears to be twice as effective as other treatments in its class. It has raised USD 126m with eyes on a near-term US IPO
Shanghai-based distributed cloud computing company PPIO has raised nearly CNY 250m (USD 37.6m) in Series A funding led by Panlin Capital, China Creation Ventures, Shanghai Zhangjiang Technology Venture Investment, and IMO Ventures.
Singapore’s Tessa Therapeutics, a biotech developer with a Hodgkin's lymphoma treatment in phase-two trials, has raised a USD 126m Series A round led by US healthcare specialist Polaris Partners.
US and China-based biotech player Degron Therapeutics has closed a USD 22m Series A round led by Med-Fine Capital.
Sequoia Capital China has led a USD 210m Series A round for Envision Digital, a Singapore-based technology developer focused on helping organisations achieve net-zero greenhouse gas emissions.